BioSpace News Archive

Drug Development

First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna’s Next Generation COVID-19 Vaccine

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participants have been dosed in the Phase 1 study of mRNA-1283, the Company’s next generation COVID-19 vaccine candidate.

March 15, 2021
·
11 min read
Drug Development

Mersana Therapeutics Announces Publication of Two Manuscripts Detailing Preclinical Studies of the Dolaflexin Platform and Upifitamab Rilsodotin (XMT-1536) in AACR Journal Molecular Cancer Therapeutics

Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the publication of two manuscripts in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research (AACR).

March 15, 2021
·
6 min read
FDA

FDA Clears Olympus’ Narrow Band Imaging® (NBI) for Use in Assessing Colonic Lesions

Olympus announced today FDA 510(k) clearance of Narrow Band Imaging ® (NBI) to assess the neoplastic potential of colorectal polyps.

March 15, 2021
·
4 min read
Business

Viewpoint Molecular Targeting(TM) Establishes Strategic Manufacturing Supply Agreement with Industry-Leader, SpectronRx, to Accelerate Build-Out of Ra-224/Pb-212 Generator (VMT-a-GEN) Production Facilities

- SpectronRx is a well-established CDMO with a reputation of supplying high-quality, GMP/Pharmaceutical grade isotopes without impurities that meet FDA standards for radiopharmaceuticals - - Building out VMT-

March 15, 2021
·
1 min read
Business

CNS Pharmaceuticals to Participate in Inaugural Emerging Growth Virtual Conference

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that John Climaco, CEO

March 15, 2021
·
3 min read
Vaica to offer a ‘Long Covid’ Remote Patient Management Kit

Vaica Medical, a leading provider in medication adherence and remote patient management (RPM) is announcing its ‘Long-Covid’ RPM kit to monitor and assist with the lingering effects Coronavirus has on recovered patient.

March 15, 2021
·
2 min read
EyeYon Medical Raises $25 million in Series C to Transform Corneal Care

EyeYon Medical announced today the completion of a $25 million in a Series C funding, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund.

March 15, 2021
·
3 min read
BioMidwest

Fresenius Kabi Introduces First-Ever Generic for Foscavir® (Foscarnet Sodium) Injection

Fresenius Kabi announced today the immediate availability in the United States of Foscarnet Sodium Injection. Fresenius Kabi Foscarnet Sodium Injection is available in 6000 mg / 250 mL bottle.

March 15, 2021
·
7 min read
BioForest

Know Labs Announces Close of Financing

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, through its proprietary electromagnetic energy technology platforms, announced today that it has closed on $14.2 million of financing.

March 15, 2021
·
4 min read
Business

Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms

Amid the vaccine roll out, 97,309 new cases of COVID-19 have been reported to the CDC. Peter Staats, M.D. Chief Medical Officer of electroCore, Inc. (Nasdaq: ECOR), outlines common COVID-19 symptoms and at-home steps that can be discussed with health care providers to reduce symptoms.

March 15, 2021
·
10 min read